If you are a person with diabetes, you already know that some drugs cannot be administered other than via injections. Today’s guest works on a solution for these medications to be taken from the inside of the cheek.

You’ll hear:

• how different kinds of drugs are absorbed
• why some drugs, macromolecular drugs, need to be delivered in injections
• how Obaris has overcome this problem
• how drugs such as Ozempic or Mounjaro could be administered painlessly

Dr. David Klein Cerrejon is the CEO of Obaris, a chemist with a PhD in pharmaceutical science specializing in drug delivery. Obaris is a Swiss startup, an ETH spin-off, that develops Octo-Patch, a small, painless patch, resembling an octopus sucker, that you can stick to the inner side of the cheek to administer drugs that are now available only in injections.

Here is more about Obaris:

https://obaris.ch/

If you've enjoyed listening, you'll make us happy by clicking "Follow" on X-Health.show and leaving a review.

The information in this podcast is for informational purposes only and should not be considered medical advice. If you have any medical questions, please consult your healthcare practitioner. The opinions on the show are Alex's or her guests. The podcast does not make any responsibility or warranties about guests statements or credibility. While the podcast makes every effort to ensure that the information shared is accurate, please let us know if you have any comments, suggestions or corrections.